CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Revenue Q3 F2025 Resulting in Positve Adjusted EBITDA of $440,665.00 with Gross sales of $5.5 Million as well as 6% increase in Gross Earnings over the prior periods
CALGARY, AB, July 2, 2025 /CNW/ - CanadaBis Capital (the "Company" or "CanadaBis Capital") (TSXV:CANB) a premium cannabis and concentrates producer, is pleased to announce its First Quarter Fiscal 2025 financial results for the three month period ending April 30, 2025.
CanadaBis Capital (TSXV:CANB), a leading player in the cannabis sector, has released its financial results for the three and nine months ended April 30, 2025. Despite a challenging market environment, the Company is pleased to report an adjusted EBITDA of positive $440,665 for Q3 2025, demonstrating resilience and operational efficiency.
Travis McIntyre, CEO of CanadaBis Capital, stated, "Our ability to achieve positive EBITDA in this challenging market is a testament to our team's dedication and our strategic focus on cost management and product innovation. The successful launch of our diamond and Keef-coated pre-rolls not only showcases our commitment to quality but also our responsiveness to market trends. The improvement in gross profit as a percentage of revenue reflects our operational efficiency. As we prepare to introduce our revolutionary vape hardware later this year, we look forward to re-establishing Stigma Grow's presence in the vape market with our innovative and high-quality offerings. As we continue to reduce our debt and optimize our operations, we are well-positioned for future growth."
Financial Highlights:
Gross Revenue: CanadaBis achieved gross revenue of $5.5 million for Q3 2025, reflecting a strategic decision to delist marginally profitable SKUs from provincial boards amid seasonally weak cannabis sales.
Gross Revenue and Net Income Insights:- Efficiency Improvement: Gross profit as a percentage of gross revenue increased by 6%, indicating a significant enhancement in operating efficiency during this period.
- Cost Savings: The Company successfully reduced Selling, General and Administrative expenses (SG&A) to $1.4 million, a significant decrease of 30% from $1.8 million in the same period last year. This cost control initiative has been crucial in maintaining positive EBITDA levels.
- Adjusted EBITDA: Despite the decrease in revenue, adjusted EBITDA remained robust at $440,665, staying on track with comparative quarters with higher gross revenue showing that cost cutting measures and optimization strategies are working giving way for larger up side in future periods.
- Debt Reduction: CanadaBis has made ...
